Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2026-03-27 @ 11:37 PM
Study NCT ID:
NCT04395456
Status:
UNKNOWN
Last Update Posted:
2021-02-21
First Post:
2020-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
Sponsor:
Amyndas Pharmaceuticals S.A.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19) | View |
Keywords: